LGALS3 and neoplasm: To confirm whether Galectin-3-β-catenin signalling blockade and sorafenib administration had a synergistic effect on tumour growth in vivo, Huh7 cells stably expressing luciferase were injected subcutaneously into BALB/c nude mice, which were then treated orally with sorafenib.